HT
EBS icon

Headlands Technologies’s Emergent Biosolutions EBS Stock Holding History

Headlands Technologies’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,969
Closed -$115K – 800
2025
Q2 		$115K Buy
+17,969
New +$103K 0.01% 597
2025
Q1 		– Sell
-1,355
Closed -$13K – 1240
2024
Q4 		$13K Sell
1,355
-4,473
-77% -$41K ﹤0.01% 980
2024
Q3 		$48.7K Sell
5,828
-136,327
-96% -$1.24M 0.01% 813
2024
Q2 		$969K Buy
+142,155
New +$612K 0.1% 171

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Headlands Technologies's EBS Position: Q3 2025 in Review

Headlands Technologies sold out of Emergent Biosolutions (EBS) in Q3 2025, closing a stake of 17,969 shares — an estimated $115K sold.

Headlands Technologies first reported a position in EBS in Q2 2024 and held it in 4 quarters. The position peaked at $969K in Q2 2024. 169 funds tracked by Wall St. Rank hold EBS as of Q3 2025.

  • Headlands Technologies reported no remaining Emergent Biosolutions position as of Q3 2025 after selling out during the quarter.
  • Headlands Technologies sold 17,969 Emergent Biosolutions shares in Q3 2025, an estimated $115K.
  • Headlands Technologies first reported a position in Emergent Biosolutions in Q2 2024 and held it in 4 quarters.
  • Headlands Technologies's Emergent Biosolutions position peaked at $969K in Q2 2024.
  • 169 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2025.

Based on Headlands Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.